Table 3.

Group marginal estimated means for all outcomes. Data expressed as mean ± standard error of the mean (SEM)

	NCS (experimental group, n = 20)	Ice (comparison group, n = 21)
Functional capacity (LEFS scores, 0–80)
Baseline	29.6 ± 1.7	34.7 ± 2.5
1 week	51.5 ± 2.9	52.2 ± 2.6
2 weeks	62.4 ± 2.3	64.7 ± 2.0
4 weeks	72.2 ± 1.9	73.0 ± 1.1
6 weeks	74.7 ± 1.3	76.3 ± 0.8
Pain at rest (VAS, 0–10)
Baseline	1.9 ± 0.4	2.2 ± 0.4
1 week	1.5 ± 0.4	0.9 ± 0.2
2 weeks	0.8 ± 0.3	0.3 ± 0.1
4 weeks	0.2 ± 0.2	0.1 ± 0.1
6 weeks	0.1 ± 0.1	0.1 ± 0.0
Pain during usual activities (VAS, 0–10)
Baseline	4.5 ± 0.5	4.6 ± 0.4
1 week	2.4 ± 0.4	2.3 ± 0.4
2 weeks	1.7 ± 0.4	1.2 ± 0.2
4 weeks	0.7 ± 0.3	0.5 ± 0.2
6 weeks	0.4 ± 0.2	0.2 ± 0.1
Oedema (Figure-of-8, cm)
Baseline	53.7 ± 0.7	52.7 ± 0.8
1 week	53.0 ± 0.7	52.0 ± 0.8
2 weeks	52.6 ± 0.7	52.1 ± 0.8
4 weeks	52.4 ± 0.6	51.7 ± 0.7
6 weeks	52.5 ± 0.7	51.9 ± 0.8
Dorsiflexion ROM (WBLT, cm)
Baseline	5.5 ± 0.8	5.9 ± 1.0
1 week	7.9 ± 0.9	9.4 ± 0.5
2 weeks	9.6 ± 0.7	10.6 ± 0.5
4 weeks	10.7 ± 0.5	11.7 ± 0.5
6 weeks	11.2 ± 0.5	11.7 ± 0.6

LEFS Lower Extremity Functional Scale, NCS neurocryostimulation, ROM range of motion, VAS visual analog scale, WBLT Weight-Bearing Lunge Test.